1197 related articles for article (PubMed ID: 15191803)
1. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
[TBL] [Abstract][Full Text] [Related]
3. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
[TBL] [Abstract][Full Text] [Related]
4. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease.
Sun M; Kong L; Wang X; Holmes C; Gao Q; Zhang GR; Pfeilschifter J; Goldstein DS; Geller AI
Hum Gene Ther; 2004 Dec; 15(12):1177-96. PubMed ID: 15684695
[TBL] [Abstract][Full Text] [Related]
6. [Synthesis of monoamines by non-monoaminergic neurons: illusion or reality?].
Ugrumov MV
J Soc Biol; 2009; 203(1):75-85. PubMed ID: 19358813
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
[TBL] [Abstract][Full Text] [Related]
8. Expanded mesencephalic precursors develop into grafts of densely packed dopaminergic neurons that reinnervate the surrounding striatum and induce functional responses in the striatal neurons.
Rodriguez-Pallares J; Parga JA; Rey P; Guerra MJ; Labandeira-Garcia JL
Synapse; 2005 Oct; 58(1):13-22. PubMed ID: 16037947
[TBL] [Abstract][Full Text] [Related]
9. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
Carlsson T; Carta M; Muñoz A; Mattsson B; Winkler C; Kirik D; Björklund A
Brain; 2009 Feb; 132(Pt 2):319-35. PubMed ID: 19039008
[TBL] [Abstract][Full Text] [Related]
10. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
St-Hilaire M; Landry E; Lévesque D; Rouillard C
Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
[TBL] [Abstract][Full Text] [Related]
11. Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration.
Lee WY; Lee EA; Jeon MY; Kang HY; Park YG
Exp Neurol; 2006 Jan; 197(1):215-24. PubMed ID: 16269145
[TBL] [Abstract][Full Text] [Related]
12. Cells of the sympathoadrenal lineage: biological properties as donor tissue for cell-replacement therapies for Parkinson's disease.
Fernandez-Espejo E; Armengol JA; Flores JA; Galan-Rodriguez B; Ramiro S
Brain Res Brain Res Rev; 2005 Sep; 49(2):343-54. PubMed ID: 16111561
[TBL] [Abstract][Full Text] [Related]
13. Dopamine synthesis by non-dopaminergic neurons expressing individual complementary enzymes of the dopamine synthetic pathway in the arcuate nucleus of fetal rats.
Ugrumov MV; Melnikova VI; Lavrentyeva AV; Kudrin VS; Rayevsky KS
Neuroscience; 2004; 124(3):629-35. PubMed ID: 14980733
[TBL] [Abstract][Full Text] [Related]
14. Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval.
Sortwell CE; Camargo MD; Pitzer MR; Gyawali S; Collier TJ
Exp Neurol; 2001 May; 169(1):23-9. PubMed ID: 11312554
[TBL] [Abstract][Full Text] [Related]
15. Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease.
Kanaan NM; Collier TJ; Marchionini DM; McGuire SO; Fleming MF; Sortwell CE
Brain Res; 2006 Jan; 1068(1):221-9. PubMed ID: 16368081
[TBL] [Abstract][Full Text] [Related]
16. Does treatment with dopamine agonists affect utilization of exogenous levodopa in the parkinsonian striatum?
Melamed E
J Neural Transm Suppl; 1995; 45():57-60. PubMed ID: 8748609
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the response to levodopa therapy after intrastriatal transplantation of autologous sympathetic neurons in patients with Parkinson disease.
Nakao N; Kakishita K; Uematsu Y; Yoshimasu T; Bessho T; Nakai K; Naito Y; Itakura T
J Neurosurg; 2001 Aug; 95(2):275-84. PubMed ID: 11780898
[TBL] [Abstract][Full Text] [Related]
18. Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine-lesioned rats: implications for Parkinson's disease.
Shukla S; Agrawal AK; Chaturvedi RK; Seth K; Srivastava N; Sinha C; Shukla Y; Khanna VK; Seth PK
J Neurochem; 2004 Oct; 91(2):274-84. PubMed ID: 15447661
[TBL] [Abstract][Full Text] [Related]
19. Selective alterations of gene expression in mice induced by MPTP.
Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
[TBL] [Abstract][Full Text] [Related]
20. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
